Osawa Yusuke, Seki Taisuke, Takegami Yasuhiko, Kusano Taiki, Makida Kazuya, Ishiguro Naoki
Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Int Orthop. 2018 Jul;42(7):1683-1688. doi: 10.1007/s00264-018-3987-7. Epub 2018 May 24.
The aim of this study was to compare the clinical outcomes of cementless total hip arthroplasty (THA) used for the treatment of osteonecrosis of the femoral head (ONFH) and for osteoarthritis (OA) at a mean ten years follow-up.
Case-control study of 78 patients (86 hips) who underwent THA for ONFH treatment (ONFH group). Patients were matched for age and sex to 78 patients (86 hips) who underwent THA for OA (OA group). We compared the clinical and patient-reported outcomes, implant survival rates, and rates of complications between the groups.
There were no between-group differences in the Harris Hip Score and in the following patient-reported outcomes at the last follow-up: Japanese Orthopedic Association Hip-Disease Evaluation Questionnaire (JHEQ) pain and movement scores and the Physical Component Summary and Role/Social Component Summary scores of Short Form-36 (SF-36). However, the mental score of the JHEQ, the Mental Component Summary score of SF-36, and The Visual Analog Scale score for satisfaction were lower for the ONFH group than for OA group. The rate of complication was equivalent between the groups: 5% for the ONFH group and 3% for the OA group. The ten year implant survival rate was equivalent between the groups, at 97.5% for the ONFH group and 98.2% for the OA group.
The functional outcomes, implant survival, and rate of complications for cementless THAs are comparable at a mean follow-up of ten years for ONFH and OA.
本研究旨在比较在平均十年随访期内,非骨水泥型全髋关节置换术(THA)用于治疗股骨头坏死(ONFH)和骨关节炎(OA)的临床结果。
对78例接受THA治疗ONFH的患者(86髋)进行病例对照研究(ONFH组)。将这些患者按年龄和性别与78例接受THA治疗OA的患者(86髋)进行匹配(OA组)。我们比较了两组之间的临床和患者报告的结果、植入物生存率以及并发症发生率。
在最后一次随访时,Harris髋关节评分以及以下患者报告的结果在两组之间没有差异:日本骨科协会髋关节疾病评估问卷(JHEQ)的疼痛和活动评分以及简短健康调查问卷(SF-36)的身体成分总结和角色/社会成分总结评分。然而,ONFH组的JHEQ心理评分、SF-36心理成分总结评分以及视觉模拟量表满意度评分低于OA组。两组之间的并发症发生率相当:ONFH组为5%,OA组为3%。两组之间的十年植入物生存率相当,ONFH组为97.5%,OA组为98.2%。
在平均十年的随访期内,非骨水泥型THA治疗ONFH和OA的功能结果、植入物生存率和并发症发生率具有可比性。